Article
In Vivo Reporter Assays Uncover Changes in Enhancer Activity Caused by Type 2 Diabetes-Associated Single Nucleotide Polymorphisms.
Diabetes - 1 Dec 2020
Eufrásio Ana, Perrod Chiara, Ferreira Fábio J, Duque Marta, Galhardo Mafalda, Bessa José
Abstract excerpt
Many single nucleotide polymorphisms (SNPs) associated with type 2 diabetes overlap with putative endocrine pancreatic enhancers, suggesting that these SNPs modulate enhancer activity and, consequently, gene expression. We performed in vivo mosaic transgenesis assays in zebrafish to quantitatively test the enhancer activity of type 2 diabetes-associated loci. Six out of 10 tested sequences are endocrine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
